Home / Investors / Press Releases

Press Releases

Neptune Announces First Quarter Results - pdf
on 15/07/2014
Neptune to Hold Conference Call to Discuss First Quarter Results - pdf
on 08/07/2014
Neptune Receives Composition Patent in Australia - pdf
on 23/06/2014
Neptune Reports Results of Annual and Special Meeting - pdf
on 20/06/2014
Neptune Sherbrooke Plant to Resume Production - Product Line Expanded - pdf
on 13/06/2014
Neptune, Acasti and NeuroBioPharm Announce Litigation Regarding its Former Chief Executive Officer - pdf
on 30/05/2014
Neptune, Acasti and NeuroBioPharm Announce Appointment of Interim CEO - pdf
on 23/05/2014
Neptune Announces Fourth Quarter and Fiscal Year Results - pdf
on 21/05/2014
NeuroBioPharm Announces Resignation of Chief Financial Officer - pdf
on 20/05/2014
Neptune Announces Proposed Director Nominees for its Upcoming Annual General Meeting - pdf
on 16/05/2014
Neptune to Hold Conference Call to Discuss Fourth Quarter and Fiscal Year Results - pdf
on 13/05/2014
Neptune Provides Update on Plant Operating Permits - pdf
on 08/05/2014
Neptune Receives CSST Report - pdf
on 08/05/2014
Neptune, Acasti and NeuroBioPharm Announce Resignation of Chief Executive Officer - pdf
on 27/04/2014
Neptune and Enzymotec Conclude Final Patent Infringement Settlement and License Agreement - pdf
on 27/04/2014
Neptune Obtains New US Patent Relating to Treatment of Alzheimer’s - pdf
on 24/04/2014
Neptune Responds to Enzymotec’s Continuous Attempts to Shift Focus from ITC Investigation - pdf
on 21/04/2014
Neptune Announces Closing of CAD$2.5 Million Private Placement - pdf
on 04/04/2014
Neptune & Acasti Give Update on Patent Litigations with Enzymotec - pdf
on 01/04/2014
Neptune Provides Update on Sherbrooke Plant - pdf
on 27/03/2014
NeuroBioPharm Extends Life of Warrants and Provides Other Corporate Updates - pdf
on 18/03/2014
Neptune Announces Closing of the Over-Allotment Option Associated with its Recently Completed Public Offering of Common Shares - pdf
on 06/03/2014
Neptune Announces Closing of US$25.0 Million Underwritten Offering of Common Shares - pdf
on 05/03/2014
Neptune Announces Pricing of US$25 million Offering of Common Shares - pdf
on 28/02/2014
Neptune Announces Proposed Offering of Common Shares - pdf
on 27/02/2014
Neptune Appoints John Moretz as Special Advisor and Nominee to its Board of Directors - pdf
on 18/02/2014
Neptune and Acasti Provide Update on Patent Litigations with Enzymotec - pdf
on 14/02/2014
Neptune Reports Third Quarter Results and Provides Update on Action Plan to Resume Operations - pdf
on 14/01/2014
Neptune Receives New Food Raw Material Certification in China - pdf
on 09/01/2014
Neptune to Hold Conference Call to Discuss Third Quarter Results - pdf
on 07/01/2014
2013
Neptune Appoints Jerald J. Wenker as Special Advisor and Nominee to Its Board of Directors - pdf
on 19/12/2013
Neptune, Acasti and Enzymotec Sign Settlement Term Sheet Resulting in Stay of ITC Investigation for 30 Days - pdf
on 18/12/2013
Neptune and Aker BioMarine Reach Patent Infringement Settlement And License Agreement - pdf
on 17/12/2013
Neptune Participates in the Equity Financing of Acasti Pharma - pdf
on 03/12/2013
Neptune Holds Annual Charity Poker Game to Benefit Vitamin Angels - pdf
on 12/11/2013
Neptune Reaffirms its Patent Position - pdf
on 12/11/2013
Neptune to Oppose CSST Statement - pdf
on 08/11/2013
Reed V. Tuckson, M.D. Joins Neptune’s Board of Directors - pdf
on 05/11/2013
Neptune Reports Second Quarter Results and Provides Update on Action Plan to Resume Operations - pdf
on 15/10/2013
Neptune Receives $12.5 Million Loan Offer from Investissement Québec - pdf
on 11/10/2013
Neptune to Hold Conference Call to Discuss Second Quarter Results - pdf
on 10/10/2013
Neptune and Rimfrost Sign Krill Oil Manufacturing and Supply Agreement - pdf
on 02/10/2013
Patent Infringement Settlements Reached Neptune Grants a Royalty Bearing License on its Patents - pdf
on 02/10/2013
Neptune Receives Additional $5 million Insurance Payment - pdf
on 26/08/2013
Neptune Awarded Canadian Composition of Matter Patent - pdf
on 16/07/2013
First Quarter Results and Update on Action Plan - pdf
on 15/07/2013
Neptune Announces Issuance of Shares - pdf
on 12/07/2013
Neptune to Hold Conference Call to Discuss First Quarter Results - pdf
on 09/07/2013
Neptune to Present at JMP Securities Healthcare Conference - pdf
on 04/07/2013
Neptune Commences Reconstruction of Sherbrooke Plant - pdf
on 28/05/2013
Neptune Reports Fiscal 2013 Results and Provides Update on Action Plan to Resume Operations - pdf
on 23/05/2013
Neptune Responds to Aker’s Continued Attempts to Deflect Attention from its Sustained Patent Infringement - pdf
on 16/05/2013
Class Action Lawsuit Against Neptune Dismissed - pdf
on 16/05/2013
Neptune to Hold Conference Call - pdf
on 09/05/2013
The U.S. International Trade Commission (ITC) Votes to Institute Patent Infringements Investigation based on Neptune & Acasti Complaint - pdf
on 16/04/2013
Neptune Provides Update on European Patent Dispute and Maintains its International Patent Strategy - pdf
on 11/04/2013
Neptune to Present at the Annual ROTH Conference - pdf
on 14/03/2013
Neptune Obtains a Third U.S. Patent on Phospholipid Compositions, Further Bolstering Neptune’s Request for an ITC Investigation - pdf
on 26/02/2013
Neptune Responds to Aker BioMarine’s Attempt to Shift the Focus from Neptune’s Major ITC Filing - pdf
on 05/02/2013
Neptune files ITC Complaint against competitors Aker, Enzymotec, Rimfrost, Olympic and others - pdf
on 31/01/2013
Neptune Obtains Allowance of Patent Specific to Krill Oil And Announces Management Reorganization - pdf
on 24/01/2013
Neptune Reports Third Quarter Results and Confirms First Insurance Payment - pdf
on 15/01/2013
Neptune to Hold Conference Call - details - pdf
on 14/01/2013
Neptune to Hold Conference Call - pdf
on 07/01/2013
2012
Royalty Prepayment Agreement with Acasti - pdf
on 04/12/2012
Opposition of Aker's Australian Patent - pdf
on 27/11/2012
Action Plan Post Incident - pdf
on 26/11/2012
Conference Call for Post Incident - pdf
on 26/11/2012
Neptune is Actively Working on Action Plan - pdf
on 16/11/2012
2012-11-12 Neptune Press Release - Explosion - pdf
on 12/11/2012
2012-11-05 Poker tournament - pdf
on 05/11/2012
Neptune Reports Second Quarter Results - pdf
on 15/10/2012
Neptune Confirms Dividend Ratio for Partial Spin-Off of NeuroBioPharm Inc. - pdf
on 04/10/2012
Neptune Dismisses Aker’s Inaccurate Allegations About Its New Patent - pdf
on 03/10/2012
Neptune Files a Second Patent Infringement Suit Against Competitors Aker, Enzymotec, and Others - pdf
on 02/10/2012
Neptune Secures Another U.S. Patent - pdf
on 01/10/2012
Neptune Announces Pricing of US$30 million Offering of Common Shares - pdf
on 25/09/2012
Neptune Announces Proposed Offering of Common Shares - pdf
on 24/09/2012
Neptune Krill Oil Specifications Sheet - pdf
on 20/09/2012
ECO Krill Oil Specifications Sheet - pdf
on 20/09/2012
Neptune Reports Preliminary Revenues on Second Quarter - pdf
on 11/09/2012
Neptune Announces Dividend-In-Kind and Record Date for Partial Spin-Off of NeuroBioPharm Inc. - pdf
on 07/09/2012
Neptune’s Competitor Claims an Illusory Victory - pdf
on 06/09/2012
Neptune & Acasti Reappoint The Howard Group as Investor Relations Consultant - pdf
on 28/08/2012
Neptune Reports First Quarter Results - pdf
on 16/07/2012
ASIAN Market Exceptional Growth Boosting Neptune’s Sales - pdf
on 21/06/2012
Neptune’s Allowance of Continuation of ‘348 Patent Strengthens Its Position in the U.S. - pdf
on 07/06/2012
Neptune Reports Preliminary Revenues on First Quarter - pdf
on 05/06/2012
Neptune to Hold Conference Call - pdf
on 30/05/2012
Neptune Reports Fiscal 2012 Results - pdf
on 25/05/2012
Neptune’s Board of Director Welcomes Dr. Harlan Waksal - pdf
on 23/05/2012
Neptune, the Only Krill Oil Manufacturer Certified as “Friend of the Sea” - pdf
on 22/05/2012
Neptune Believes the Australian Patent Office Will Reconsider its Grant of Aker’s Australian Patent - pdf
on 22/05/2012
Neptune Confirms its Pre-eminence in the Australian Market - pdf
on 08/05/2012
NKO® Ambassador John Elway to Speak at SupplySide MarketPlace (NYC) and to Visit Neptune’s Booth - pdf
on 03/05/2012
Neptune Appoints New IR firm for the US - pdf
on 27/03/2012
Neptune Signs John Elway, NFL Hall-of-Famer, as Official Brand Ambassador - pdf
on 27/03/2012
Neptune Technologies & Bioressources Investing Over $20M in Sherbrooke - pdf
on 09/03/2012
Neptune Technologies & Bioressources investing over $20M in Sherbrooke - pdf
on 09/03/2012
Neptune to Present at The 24th Annual Roth Conference - pdf
on 06/03/2012
Neptune Must Again Rectify Competitor’s Misleading Statement - pdf
on 01/03/2012
Neptune Premium Krill Oil, NKO® Enters the Mass Market with Jamieson Laboratories, the Largest Brand in Canada - pdf
on 15/02/2012
Neptune Acquires Common Shares of Acasti Pharma - pdf
on 13/02/2012
Neptune, Aker and Schiff Agree to Stay of Litigation during Patent Re-examination Proceedings - pdf
on 02/02/2012
Neptune Reports Third Quarter Results - pdf
on 17/01/2012
Neptune Pursues its IP Strategy with Continuation Applications - pdf
on 12/01/2012
ERRATUM - Neptune To Hold Conference Call - pdf
on 11/01/2012
Neptune To Hold Conference Call - pdf
on 11/01/2012
2011
Neptune Starts Phase-I Sherbrooke Plant Expansion - pdf
on 12/12/2011
Neptune Reports Preliminary Revenues on Record Quarter - pdf
on 01/12/2011
Neptune Technologies & Bioressources Common Shares Graduate to the TSX - pdf
on 24/11/2011
Neptune reaffirms its confidence in its patent protection and the US prosecution process - pdf
on 17/11/2011
Neptune Technologies & Bioressources Announces the Inssuance of an Additional Key US Patent - pdf
on 16/11/2011
Neptune Receives TSX Conditional Approval - pdf
on 27/10/2011
Neptune Reports Second Quarter Results - pdf
on 13/10/2011
Neptune Launches Patent Infringement Litigation against Aker Biomarine ASA, Enzymotec Ltd., and Others - pdf
on 06/10/2011
Neptune Technologies & Bioressources Obtains New Patent Directed to Compositions of Omega-3 Fatty Acid Phospholipids including Krill Oil - pdf
on 05/10/2011
Neptune To Hold Conference Call - pdf
on 04/10/2011
Neptune’s customer is awarded “Product of the Year 2011” in Denmark - pdf
on 28/09/2011
Neptune subscirbes to Acasti Pharma’s rights offering - pdf
on 19/09/2011
Neptune penetrates Asia by partnering with Chinese SKFC, the world's largest fleet owner of fishing Vessels - pdf
on 19/09/2011
Neptune Reports First Quarter Results - pdf
on 16/08/2011
Neptune Technologies & Bioressources Confirms Dividend of Acasti Rights - pdf
on 06/07/2011
Neptune Technologies & Bioressources Inc. welcomes Dr. Anthony Holler to its Board of Directors - pdf
on 05/07/2011
Neptune Secures and Increases US Food, Drug, Mass and Club Distribution - pdf
on 22/06/2011
Neptune Stronger in Asia by Penetrating the Indian Market - pdf
on 06/06/2011
Neptune Reports Fiscal 2011 Results - pdf
on 30/05/2011
Neptune Technologies & Bioressources Closes Oversubscribed Private Placement Financing - pdf
on 13/05/2011
Neptune Technologies & Bioressources Environmental Responsibility and Business Conduct Acknowledged by NSF International - pdf
on 09/05/2011
Neptune Technologies & Bioressources Secures an additional $2.865M - pdf
on 20/04/2011
Neptune Technologies & Bioressources Announces a Private Placement Financing of Approximately $10 Million USD - pdf
on 19/04/2011
Neptune is Nominated as a Finalist for the Nutraceutical & Business Technology Awards 2011 and Prolongs US IR Agreement - pdf
on 14/04/2011
Bayer Healthcare’s Artic Wonder Market Test Succeeds with Neptune Krill Oil Leading to US National Launch - pdf
on 08/04/2011
Neptune Technologies & Bioressources Inc. subsidiary Acasti Pharma Inc. Shares to Trade on the TSX-Venture on March 31st - pdf
on 30/03/2011
Neptune Reports on Preliminary 2011 Year End Results - pdf
on 22/03/2011
Neptune Technologies & Bioressources Inc. to Present at the Roth OC Growth Stock Conference - pdf
on 28/02/2011
Neptune Technologies & Bioressources Inc. Reports Net Profit for the Third Quarter - pdf
on 13/01/2011
Neptune Technologies & Bioressources Inc. to Host Management Discussion Teleconference at 9:00 a.m. on January 14th - pdf
on 12/01/2011
2010
Neptune Technologies & Bioressources Announces A Private Placement of $2,646,500 - pdf
on 12/10/2010
Neptune Technologies & Bioressources Inc. Announces Major Breakthrough in the Omega-3 Market - pdf
on 29/09/2010
Neptune Technologies & Bioressources Inc. subsidiary Acasti Pharma Inc. reports superior effect of Drug Candidate CaPre™ over Lovaza - pdf
on 29/09/2010
Neptune Appoints IR firm for the US - pdf
on 22/09/2010
Neptune Reports Net Profit for the First Quarter - pdf
on 14/07/2010
Neptune Announces Cancellation of Financing - pdf
on 15/06/2010
Neptune Reports Fiscal 2010 Results - pdf
on 28/05/2010
NKO® Awarded Best Product of 2010 - pdf
on 26/05/2010
Neptune Announces Brokered $15.0 Million Private Placement Financing - pdf
on 04/05/2010
Acasti Pharma Inc. to present at the ATVB 2010 council of the American Heart Association - pdf
on 08/04/2010
Neptune Reports Preliminary 2010 Year End Sales Results and Acasti Nomination - pdf
on 04/04/2010
Neptune Technologies & Bioressources Inc. named as part of 2010 TSX Venture 50 - pdf
on 03/03/2010
Neptune Technologies & Bioressources Reports Third Quarter Results - pdf
on 14/01/2010
Investors

Neptune’s new Sherbrooke, Quebec, Canada Plant.